Incidence and outcome of mild cognitive impairment in a population-based prospective cohort
By S. Larrieu, L. Letenneur, J. Orgogozo, C. Fabrigoule, H. Amièva, N. L. Carret, P. Barberger‐Gateau, Jean-François Dartigues. Neurology, 2002
678 citations recorded by the source corpus.
Subfields: Neurology, Physiology, Psychiatry and Mental health
View Paper: https://www.semanticscholar.org/paper/811362cf28ffc35f48cf7482f51abb8f301ba1aa
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Neurology
- William E. Klunk
- Reisa A. Sperling
- Keith A. Johnson
- Nick C Fox
- Jennifer J. Manly
- Yaakov Stern
- John C. Morris
- Ronald C. Petersen
In Physiology
- Yaakov Stern
- Richard P. Mayeux
- Reisa A. Sperling
- John C. Morris
- Nick C Fox
- A. Mitchell
- Ronald C. Petersen
- William E. Klunk
In Psychiatry and Mental health
- Reisa A. Sperling
- Richard P. Mayeux
- Yaakov Stern
- Ronald C. Petersen
- John C. Morris
- A. Mitchell
- Nick C Fox
- Jennifer J. Manly
Citations in the corpus
- Frequency and course of mild cognitive impairment in a multiethnic community (2008, background): “In this study, black and Hispanic subjects, and those with less than a high school education, were not at greater risk for development of MCI; however, these groups were at greater risk for development of AD even when MCI status at initial visit was taken into account.”
- Mild cognitive impairment (2006, background): “Overall, the risk of dementia appears to be increased between threefold and eightfold [22,33,42].”
- Rate of progression of mild cognitive impairment to dementia – meta‐analysis of 41 robust inception cohort studies (2009, background): “…0.007 0.016 0.011 Palmer et al. (2007) (56) 3 Community 47 0.574 0.191 Zanetti et al. (2006) (55) 3 Community 65 0.308 0.169 0.138 0.103 0.056 0.046 Larrieu et al. (2002) (60) 5 Community 58 0.448 0.090 Ritchie et al. (2001) (57) 3 Community 27 0.111 0.037 Non-Mayo clinic Definition of MCI…”
- Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models (2014, background): “Most studies of MCI patients show consistent impairments in verbal recall (Larrieu et al., 2002; Tuokko et al., 2005; Kryscio et al., 2006) and a decline in general memory functioning (Tuokko et al., 2005; Bondi et al., 2008).”
- Brain imaging in Alzheimer disease. (2012, background): “Two community-based studies have shown over one-third of patients diagnosed with MCI at baseline may eventually return to normal cognition (Larrieu et al. 2002; Ganguli et al. 2004).”
- Aerobic Exercise and Neurocognitive Performance: a Meta-Analytic Review of Randomized Controlled Trials (2010, neutral): “elevated risk for Alzheimer’s disease (24).”
- Mild cognitive impairment as a clinical entity and treatment target. (2005, background): “ity” that is responsible for the group variability over time.(10) Another important aspect of the implementation of the criteria concerns the manner in which the criteria are applied.”